SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Controlling Off-Label Medication Use
2 references·0 citing·6 second hop
Controlling Off-Label Medication Use (2009)Controlling Off-Label Medication Use(Re)defining biopharmaceutical (2008)(Re)defining biopharmaceuticalCoverage Options For Promising Technologies: Medicare’s ‘Coverage With Evidence Development’ (2006)Coverage Options For Promisin…Coverage with Evidence Development: An examination of conceptual and policy issues (2007)Funding the Unfundable (2010)Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers (2010)A guide to efficient keyword, sequence and classification search strategies for biopharmaceutical drug-centric patent landscape searches - A human recombinant insulin patent landscape case study (2011)Knowledge-flows and firm performance (2012)Forecasting of emerging therapeutic monoclonal antibodies patents based on a decision model (2018)
this work references cited by second hop

References

  • 2006Coverage Options For Promising Technologies: Medicare’s ‘Coverage With Evidence Development’210 cited
  • 2008(Re)defining biopharmaceutical201 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work